4.12 USD
↘ 0.18 (4.19%)AT CLOSE (03:59 PM EST)
Atea Pharmaceuticals, Inc. Common Stock (AVIR) trades at $4.15 per share. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, AVIR appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 16, 2026.